Hello all, I was wondering, are there any Hep B sufferers in the UK that have been prescribed the newer formulation of Tenofovir (Tenofovir alafenamide; TAF)? I know it is associated with a significantly lower risk of reduced kidney function. From what I have read in the available medical literature, it has a greater plasma stability and can deliver tenofovir to hepatocytes more efficiently than the old formulation, at only one-tenth of the dose.
I am aware that in Europe and the US the drug has been approved for use in Hep B patients but in the UK, NICE has not appraised its use due to Gilead failing to submit evidence to support its use. Nonetheless, I have found published research on clinical trials conducted under the supervision of King's College Hospital NHS Foundation Trust consultants, supporting the use of TAF for Heb B patients. Similarly, the British National Formulary indicates the use of TAF in chronic Hep B.
I am about to lose one kidney due to an unrelated health problem and I am worried about the impact that Tenofovir Disoproxil Fumarate will have on my remaining kidney.
Any information you may have about this would mean the world to me!